Jorge Arnold
Overview
Explore the profile of Jorge Arnold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Idalsoaga F, Diaz L, Guizzetti L, Dunn W, Mehta H, Arnold J, et al.
Aliment Pharmacol Ther
. 2025 Feb;
PMID: 39967231
Several dynamic models predict mortality and corticosteroid response in alcohol-associated hepatitis (AH), yet no consensus exists on the most effective model. This study aimed to assess predictive models for corticosteroid...
2.
Idalsoaga F, Ayares G, Diaz L, Arnold J, Ayala-Valverde M, Hudson D, et al.
Liver Res
. 2025 Feb;
7(1):35-46.
PMID: 39959695
Alcohol-related liver disease (ALD) encompasses a spectrum of diseases caused by excessive alcohol consumption. ALD includes hepatic steatosis, steatohepatitis, variable degrees of fibrosis, cirrhosis, and alcohol-associated hepatitis (AH), the latter...
3.
Arnold J, Avila E, Idalsoaga F, Diaz L, Ayala Valverde M, Ayares G, et al.
eGastroenterology
. 2025 Feb;
1(2):e100009.
PMID: 39943997
In hepatorenal syndrome-acute kidney injury (HRS-AKI), accurate and early diagnosis is crucial. HRS is a severe condition seen in advanced cirrhosis, requiring prompt recognition and proper management to enhance patient...
4.
Dunn W, Li Y, Singal A, Simonetto D, Diaz L, Idalsoaga F, et al.
Hepatology
. 2024 Apr;
80(5):1196-1211.
PMID: 38607809
Background And Aims: Alcohol-associated hepatitis (AH) poses significant short-term mortality. Existing prognostic models lack precision for 90-day mortality. Utilizing artificial intelligence in a global cohort, we sought to derive and...
5.
Diaz L, Fuentes-Lopez E, Idalsoaga F, Ayares G, Corsi O, Arnold J, et al.
J Hepatol
. 2023 Nov;
80(3):409-418.
PMID: 37992972
Background & Aims: The long-term impact of alcohol-related public health policies (PHPs) on disease burden is unclear. We aimed to assess the association between alcohol-related PHPs and alcohol-related health consequences....
6.
Diaz L, Fuentes-Lopez E, Ayares G, Idalsoaga F, Arnold J, Ayala Valverde M, et al.
JHEP Rep
. 2023 Jul;
5(8):100727.
PMID: 37456675
Background & Aims: Model for End-Stage Liver Disease (MELD) score better predicts mortality in alcohol-associated hepatitis (AH) but could underestimate severity in women and malnourished patients. Using a global cohort,...
7.
Omran M, Omr M, Mohamed A, Abdelghafour R, Muharram N, Hassan M, et al.
Eur J Gastroenterol Hepatol
. 2023 Jul;
35(8):874-880.
PMID: 37395240
Aim: This study aimed to develop a noninvasive test for identifying patients with nonalcoholic fatty liver disease (NAFLD) based on clinical and routine laboratory data. Methods: The developed model 'NAFLD...
8.
Benitez C, Arnold J, Cambindo V, Schoenfeldt F, Cancino A, Ibanez S, et al.
Ann Hepatol
. 2023 Jun;
28(5):101128.
PMID: 37331597
Introduction And Objectives: Acute-on-chronic liver failure (ACLF) is associated with reduced short-term survival, and liver transplantation is frequently the only therapeutic option. Nonetheless, the post-transplantation prognosis seems to be worse...
9.
Ayares G, Idalsoaga F, Arnold J, Fuentes-Lopez E, Arab J, Diaz L
J Clin Exp Hepatol
. 2022 Nov;
12(6):1480-1491.
PMID: 36340308
Hazardous alcohol consumption causes approximately 4% of deaths globally, constituting one of the leading risk factors for the burden of the disease worldwide. Alcohol has several health consequences, such as...
10.
Ayares G, Idalsoaga F, Diaz L, Arnold J, Arab J
J Clin Exp Hepatol
. 2022 Sep;
12(5):1333-1348.
PMID: 36157148
Alcohol-associated liver disease is one of the main causes of chronic liver disease. It comprises a clinical-histologic spectrum of presentations, from steatosis, steatohepatitis, to different degrees of fibrosis, including cirrhosis...